Gartner T K, Gerrard J M, White J G, Williams D C
Blood. 1981 Jul;58(1):153-7.
Platelets from patients with several bleeding disorders (congenital afibrinogenemia, Glanzmann's thrombasthenia, gray platelet syndrome, and Hermansky-Pudlak syndrome) were evaluated for both platelet-bound and platelet-free hemagglutination activities. Thrombin and A23187 activated afibrinogenemic, Hermansky-Pudlak, and thrombasthenic platelets had normal platelet-bound hemagglutination activity. Gray platelets activated by the same agents had deficient platelet-bound hemagglutination activity. In contrast, thrombin-activated afibrinogenemic, gray, and thrombasthenic platelets lacked platelet-free hemagglutination activity. Only thrombin-activated Hermansky-Pudlak platelets had a normal level of platelet-free hemagglutination activity. On the basis of these results and the distinguishing characteristics of the defective platelets, it is concluded that the alpha-granules are the origin of the enhanced hemagglutination activity. Furthermore, it is suggested that the insufficiency of the platelet-bound agglutinin may be the cause of the inability of gray platelets to aggregate normally in response to thrombin.
对患有多种出血性疾病(先天性无纤维蛋白原血症、血小板无力症、灰色血小板综合征和Hermansky-Pudlak综合征)患者的血小板进行了血小板结合和游离血凝活性评估。凝血酶和A23187激活的无纤维蛋白原血症、Hermansky-Pudlak综合征和血小板无力症患者的血小板具有正常的血小板结合血凝活性。由相同试剂激活的灰色血小板的血小板结合血凝活性不足。相比之下,凝血酶激活的无纤维蛋白原血症、灰色和血小板无力症患者的血小板缺乏游离血凝活性。只有凝血酶激活的Hermansky-Pudlak综合征患者的血小板具有正常水平的游离血凝活性。基于这些结果以及缺陷血小板的特征,得出α颗粒是血凝活性增强的来源的结论。此外,有人提出血小板结合凝集素不足可能是灰色血小板无法对凝血酶正常聚集的原因。